ZimVie, Zimmer Biomet's spine and dental spinoff, saw a 6.4 percent increase in dental sales during the first quarter of 2022.
5 notes from the company's first quarter:
1. ZimVie reported $120.6 million in sales from its dental segment, an increase of $7.2 million.
2. The company said the increase in sales stemmed from the growth of implant and digital dentistry net sales.
3. ZimVie saw a net loss of $25.7 million, a decline of $26.1 million compared to the first quarter of 2021.
4. Adjusted net income was $13.1 million, a decline of $7.6 million compared to the same period in 2021.
5. ZimVie is expecting to reach $1 billion in net sales by Dec. 31.